A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)

A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)

Publication date: Aug 04, 2020

The primary objective of this early Phase 1 study is to identify the V591 dose that achieves the target immune response in humans based on preclinical or early clinical data.

Concepts Keywords
A1C Alternate telephone email
Abdominal Pain Antiviral biologic product
Alcohol Abdominal pain
Allergic Reaction Allergic reaction
Allergies Uncontrolled pulmonary disorders
Anaphylactic Reaction Tattoo scar
Anaphylaxis SARS
Angioedema Disease uncontrolled hypertension
Antibodies Severe allergies
Antigen Systemic allergic reaction
Antiviral Contraception
Asthma Contraceptive method
Autoimmune Autologous blood transfusions
Biomedical Major surgery
Blood Vaccination
Blood Product Organ transplant
Blood Transfusion Chemotherapies
Blood Transfusions Medical specialties
BMI Health
Body Mass Medicine
Breastfeeding Vaccines
Cardiomyopathies RTT
Chemotherapies Coronavirus disease
Chronic Kidney Disease Zoonoses
Chronic Pulmonary Disease COVID-19 vaccine
Coagulation Hepatitis
Cocaine Antibodies
Congenital
Contraception
Contraceptive
COPD
Coronary Artery Disease
Coronavirus
Corticosteroids
Diabetes
Diabetes Mellitus
ECG
Electrocardiogram
Glycated Hemoglobin
HBsAg
Heart Disease
Heart Failure
Hepatitis
Hepatitis Antibodies
Heterosexual
HIV
Hypertension
Immunocompromised
Immunodeficiency
Immunogenicity
Immunoglobulin
Immunosuppressive Drugs
Infection
Inflammatory Bowel Disease
Informed Consent
Intramuscular
Intramuscular Injection
Ischemic
Juvenile Rheumatoid Arthritis
Lactating
Legal Guardian
Leukemia
Liver Disease
Lymphoma
Malignancy
Merck
MERS
Nicotine
Nicotine Patch
Nursing
Obesity
Oocyte
Opioid
Organ
PCR
Physical Examination
Polymerase Chain Reaction
Pregnancy
Pregnancy Test
Prophylaxis
Psychiatric Disorder
Pulmonary
Pulmonary Hypertension
Randomization
Rheumatoid Arthritis
SARS
Serum
Sexual Activity
Sickle
Smoked
Smoking
Sperm
Systemic Lupus Erythematosus
Tattoo
Telephone
Thalassemia
Thrombocytopenia
Tolerability
Topical
Urine
Urine Test
Urticaria
Vaccination
Vaccine
Venipuncture
Viral Load
Virus
Vital Sign
VS
Weakened Immune System

Semantics

Type Source Name
disease VO COVID-19 vaccine
disease VO vaccination
disease MESH infection
disease MESH lifestyle
disease MESH men
disease VO vaccine
disease MESH anaphylaxis
disease MESH urticaria
disease MESH angioedema
disease MESH allergic reaction
disease MESH congenital
disease IDO acquired immunodeficiency
disease MESH HIV infection
pathway REACTOME HIV Infection
disease MESH lymphoma
disease MESH leukemia
disease MESH systemic lupus erythematosus
pathway KEGG Systemic lupus erythematosus
disease MESH rheumatoid arthritis juvenile
disease MESH rheumatoid arthritis
pathway KEGG Rheumatoid arthritis
disease MESH inflammatory bowel disease
disease MESH thrombocytopenia
disease VO intramuscular vaccination
disease MESH chronic obstructive pulmonary disease
disease MESH asthma
pathway KEGG Asthma
disease MESH syndrome
disease MESH hypertension
disease MESH heart disease
disease MESH disease chronic
disease MESH pulmonary hypertension
disease MESH thalassemia
disease MESH chronic kidney disease
disease MESH obesity
disease MESH heart failure
disease MESH coronary artery disease
disease MESH cardiomyopathies
disease MESH sickle cell disease
disease MESH Type 2 diabetes mellitus
disease MESH psychiatric disorder
disease MESH cancer
disease MESH latex allergy
drug DRUGBANK Hepatitis B Vaccine (Recombinant)
disease VO Hepatitis B surface antigen
disease MESH hepatitis C
pathway KEGG Hepatitis C
disease IDO immunodeficiency
disease MESH viral load
disease MESH liver disease
disease IDO antiviral
drug DRUGBANK Ethanol
drug DRUGBANK Cocaine
disease MESH opioid abuse
drug DRUGBANK Nicotine
disease MESH smokers
disease MESH tattoo
disease MESH scar
disease VO vaccination site
disease MESH emergency
disease VO pregnant women
drug DRUGBANK Etoperidone
disease MESH Coronavirus Infections

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *